-
1
-
-
34247561439
-
Tiotropium in combination with placebo, salmeterol, or fluticasone- salmeterol for treatment of chronic obstructive pulmonary disease: A randomized trial
-
Aaron S D, Bishop G, Anthony J et al. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med: 2007; 146 08 545 555 (Pubitemid 351650535)
-
(2007)
Annals of Internal Medicine
, vol.146
, Issue.8
, pp. 545-555
-
-
Aaron, S.D.1
Vandemheen, K.L.2
Fergusson, D.3
Maltais, F.4
Bourbeau, J.5
Goldstein, R.6
Balter, M.7
O'Donnell, D.8
McIvor, A.9
Sharma, S.10
Bishop, G.11
Anthony, J.12
Cowie, R.13
Field, S.14
Hirsch, A.15
Hernandez, P.16
Rivington, R.17
Road, J.18
Hoffstein, V.19
Hodder, R.20
Marciniuk, D.21
McCormack, D.22
Fox, G.23
Cox, G.24
Prins, H.B.25
Ford, G.26
Bleskie, D.27
Doucette, S.28
Mayers, I.29
Chapman, K.30
Zamel, N.31
FitzGerald, M.32
more..
-
2
-
-
0031940695
-
Efficacy and safety of inhaled corticosteroids. New developments
-
Barnes P J, Pedersen S, Busse W W. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med: 1998; 157 3 Pt 2 51 53
-
(1998)
Am J Respir Crit Care Med
, vol.157
, Issue.3 PART 2
, pp. 51-53
-
-
Barnes, P.J.1
Pedersen, S.2
Busse, W.W.3
-
3
-
-
33847172367
-
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
-
DOI 10.1056/NEJMoa063070
-
Calverley P M, Anderson J A, Celli B et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med: 2007; 356 775 789 (Pubitemid 46294610)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.8
, pp. 775-789
-
-
Calverley, P.M.A.1
Anderson, J.A.2
Celli, B.3
Ferguson, G.T.4
Jenkins, C.5
Jones, P.W.6
Yates, J.C.7
Vestbo, J.8
-
4
-
-
0034457885
-
HIV protease inhibitor-related lipodystrophy syndrome
-
DOI 10.1086/313854
-
Carr A. HIV protease inhibitor-related lipodystrophy syndrome. Clin Infect Dis: 2000; 30 02 S135 S142 (Pubitemid 32268981)
-
(2000)
Clinical Infectious Diseases
, vol.30
, Issue.SUPPL. 2
-
-
Carr, A.1
-
5
-
-
0032849379
-
Cushing's syndrome and severe adrenal suppression in patients treated with ritonavir and inhaled nasal fluticasone [3]
-
Chen F, Kearney T, Robinson S et al. Cushing's syndrome and severe adrenal suppression in patients treated with ritonavir and inhaled nasal fluticasone. Sex Transm Infect: 1999; 75 04 274 (Pubitemid 29420123)
-
(1999)
Sexually Transmitted Infections
, vol.75
, Issue.4
, pp. 274
-
-
Chen, F.1
Kearney, T.2
Robinson, S.3
Daley-Yates, P.T.4
Waldron, S.5
Churchill, D.R.6
-
7
-
-
57049135358
-
Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: A systematic review and meta-analysis
-
Drummond M B, Dasenbrook E C, Pitz M W et al. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA: 2008; 300 2407 2416
-
(2008)
JAMA
, vol.300
, pp. 2407-2416
-
-
Drummond, M.B.1
Dasenbrook, E.C.2
Pitz, M.W.3
-
9
-
-
33750049935
-
Use of inhaled corticosteroids and the risk of fracture
-
DOI 10.1378/chest.130.4.1082
-
Hubbard R, Tattersfield A, Smith C et al. Use of inhaled corticosteroids and the risk of fracture. Chest: 2006; 130 1082 1088 (Pubitemid 44583738)
-
(2006)
Chest
, vol.130
, Issue.4
, pp. 1082-1088
-
-
Hubbard, R.1
Tattersfield, A.2
Smith, C.3
West, J.4
Smeeth, L.5
Fletcher, A.6
-
10
-
-
0037115164
-
Inhaled corticosteroids and hip fracture: A population-based case-control study
-
DOI 10.1164/rccm.200206-606OC
-
Hubbard R B, Smith C J, Smeeth L et al. Inhaled corticosteroids and hip fracture: a population-based case-control study. Am J Respir Crit Care Med: 2002; 166 12 Pt 1 1563 1566 (Pubitemid 36015950)
-
(2002)
American Journal of Respiratory and Critical Care Medicine
, vol.166
, Issue.12 PART 1
, pp. 1563-1566
-
-
Hubbard, R.B.1
Smith, C.J.P.2
Smeeth, L.3
Harrison, T.W.4
Tattersfield, A.E.5
-
11
-
-
33646016085
-
Cushing's syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone
-
Johnson S R, Marion A A, Vrchoticky T et al. Cushing's syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone. J Pediatr: 2006; 148 386 388
-
(2006)
J Pediatr
, vol.148
, pp. 386-388
-
-
Johnson, S.R.1
Marion, A.A.2
Vrchoticky, T.3
-
12
-
-
2942707641
-
Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients
-
DOI 10.1530/eje.0.1500687
-
Kannisto S, Laatikainen A, Taivainen A et al. Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients. Eur J Endocrinol: 2004; 150 687 690 (Pubitemid 38786539)
-
(2004)
European Journal of Endocrinology
, vol.150
, Issue.5
, pp. 687-690
-
-
Kannisto, S.1
Laatikainen, A.2
Taivainen, A.3
Savolainen, K.4
Tukiainen, H.5
Voutilainen, R.6
-
13
-
-
80054769146
-
Drug interaction with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma
-
Kroiss M, Quinkler M, Lutz W K et al. Drug interaction with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma. Clin Endocrinol: 2011; 75 585 591
-
(2011)
Clin Endocrinol
, vol.75
, pp. 585-591
-
-
Kroiss, M.1
Quinkler, M.2
Lutz, W.K.3
-
14
-
-
21644483913
-
Metabolism and disposition of the HIV-1 protease inhibitor lopinavir (ABT-378) given in combination with ritonavir in rats, dogs, and humans
-
DOI 10.1023/B:PHAM.0000041457.64638.8d
-
Kumar G N, Jayanti V K, Johnson M K et al. Metabolism and disposition of the HIV-1 protease inhibitor lopinavir (ABT-378) given in combination with ritonavir in rats, dogs, and humans. Pharm Res: 2004; 21 1622 1630 (Pubitemid 41184393)
-
(2004)
Pharmaceutical Research
, vol.21
, Issue.9
, pp. 1622-1630
-
-
Kumar, G.N.1
Jayanti, V.K.2
Johnson, M.K.3
Uchic, J.4
Thomas, S.5
Lee, R.D.6
Grabowski, B.A.7
Sham, H.L.8
Kempf, D.J.9
Denissen, J.F.10
Marsh, K.C.11
Sun, E.12
Roberts, S.A.13
-
15
-
-
0037131879
-
Genetic contribution to variable human CYP3A-mediated metabolism
-
DOI 10.1016/S0169-409X(02)00066-2, PII S0169409X02000662
-
Lamba J K, Lin Y S, Schuetz E G et al. Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev: 2002; 54 1271 1294 (Pubitemid 35284253)
-
(2002)
Advanced Drug Delivery Reviews
, vol.54
, Issue.10
, pp. 1271-1294
-
-
Lamba, J.K.1
Lin, Y.S.2
Schuetz, E.G.3
Thummel, K.E.4
-
16
-
-
36749017545
-
Drugs as CYP3A probes, inducers and inhibitors
-
Liu Y T, Hao H P, Liu C X et al. Drugs as CYP3A probes, inducers and inhibitors. Drug Metab Rev: 2007; 39 699 721
-
(2007)
Drug Metab Rev
, vol.39
, pp. 699-721
-
-
Liu, Y.T.1
Hao, H.P.2
Liu, C.X.3
-
18
-
-
77954233206
-
Body composition after endogenous (Cushing's syndrome) and exogenous (rheumatoid arthritis) exposure to glucocorticoids
-
Resmini E, Farkas C, Murillo B et al. Body composition after endogenous (Cushing's syndrome) and exogenous (rheumatoid arthritis) exposure to glucocorticoids. Horm Metab Res: 2010; 42 613 618
-
(2010)
Horm Metab Res
, vol.42
, pp. 613-618
-
-
Resmini, E.1
Farkas, C.2
Murillo, B.3
-
19
-
-
0036899187
-
Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom
-
DOI 10.1136/adc.87.6.457
-
Todd G R, Acerini C L, Ross-Russell R et al. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child: 2002; 87 457 461 (Pubitemid 35440691)
-
(2002)
Archives of Disease in Childhood
, vol.87
, Issue.6
, pp. 457-461
-
-
Todd, G.R.G.1
Acerini, C.L.2
Ross-Russell, R.3
Zahra, S.4
Warner, J.T.5
McCance, D.6
-
20
-
-
0031931102
-
Protease inhibitors as inhibitors of human cytochromes P450: High risk associated with ritonavir
-
Von Moltke L L, Greenblatt D J, Grassi J M et al. Protease inhibitors as inhibitors of human cytochromees P450: high risk associated with ritonavir. J Clin Pharmacol: 1998; 38 106 111 (Pubitemid 28117365)
-
(1998)
Journal of Clinical Pharmacology
, vol.38
, Issue.2
, pp. 106-111
-
-
Von Moltke, L.L.1
Greenblatt, D.J.2
Grassi, J.M.3
Granda, B.W.4
Duan, S.X.5
Fogelman, S.M.6
Daily, J.P.7
Harmatz, J.S.8
Shader, R.I.9
-
21
-
-
66149168940
-
Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: Description of 4 new cases and review of the literature
-
Valin N, De Castro N, Garrait V et al. Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature. J Int Assoc Physicians AIDS Care (CHIC): 2009; 8 113 121
-
(2009)
J Int Assoc Physicians AIDS Care (CHIC)
, vol.8
, pp. 113-121
-
-
Valin, N.1
De Castro, N.2
Garrait, V.3
-
22
-
-
79953193793
-
Mitotane has a strong and a durable inducing effect on CYP3A4 activity
-
van Erp N P, Guchelaar H J, Ploeger B A et al. Mitotane has a strong and a durable inducing effect on CYP3A4 activity. Eur J Endocrinol: 2011; 164 621 626
-
(2011)
Eur J Endocrinol
, vol.164
, pp. 621-626
-
-
Van Erp, N.P.1
Guchelaar, H.J.2
Ploeger, B.A.3
|